Table 1 KLHL17 status in patients with non-small cell lung cancer according to clinicopathological characteristics.

From: Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway

Characteristics

Number of patients

KLHL17 negative or weak expression

KLHL17 overexpression

P value

Age (years)

   

0.482

 <60

90

55

35

 

 ≥60

83

55

28

 

Gender

   

0.656

 Female

53

35

18

 

 Male

120

75

45

 

Smoking status

   

0.824

 Yes

124

58

66

 

 No

49

22

27

 

Histopathology

   

0.343

 ADC

74

36

38

 

 SCC

99

41

58

 

Differentiation

   

0.022

 Well-moderate

83

60

23

 

 Poor

90

50

40

 

Size

   

<0.001

 ≤3 cm

90

72

18

 

 >3 cm

83

38

45

 

Nodal status

   

0.004

 N0

109

78

31

 

 N1, N2, N3

64

32

32

 

TNM stage

   

0.004

 I

80

60

20

 

 II–III

93

50

43

 
Back to article page